Jan 27, 2026
Most ViewedHow does ivermectin modulation of PAK1 compare to dedicated PAK1 inhibitors in preclinical cancer models?
both reduce PAK1-driven signaling in preclinical cancer models, but they do so by different molecular routes and with different translational implications: ivermectin promotes proteasome-mediated degr...